| Syngene International Ltd | Industry : (Healthcare) | |
|---|---|---|
|
BSE Code : 539268 |
NSE Symbol : SYNGENE |
P/E(TTM) : 60.79 |
|
ISIN Demat : INE398R01022 |
Div & Yield% : 0.19 |
EPS(TTM) : 10.86 |
|
Book Value(₹) : 114.67 |
Market Cap(₹Cr) : 26,600.05 |
Face Value(₹) : 10.00 |
| Particulars | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| INCOME : | |||||
| Sales Turnover | - | - | - | - | - |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 3,373.30 | 3,203.10 | 3,193.50 | 2,601.40 | 2,179.40 |
| Other Income | 102.50 | 88.00 | 70.90 | 107.60 | 99.60 |
| Stock Adjustments | -17.10 | -56.60 | 42.00 | 21.60 | 25.20 |
| Total Income | 3,458.70 | 3,234.50 | 3,306.40 | 2,730.60 | 2,304.20 |
| EXPENDITURE : | |||||
| Raw Materials | 868.30 | 839.10 | 902.20 | 770.60 | 551.70 |
| Power and Fuel Cost | 55.00 | 54.20 | 69.20 | 64.40 | 57.40 |
| Other Manufacturing Expenses | 267.90 | 227.40 | 208.30 | 160.80 | 140.60 |
| Selling and Administration Expenses | 364.80 | 295.60 | 226.70 | 157.90 | 123.10 |
| Miscellaneous Expenses | 40.90 | 101.30 | 82.60 | 63.60 | 20.30 |
| Employee Benefit Expenses | 841.70 | 761.20 | 812.20 | 697.80 | 641.50 |
| Less: Preoperative Expenditure | - | - | - | - | - |
| Total Expenses | - | - | - | - | - |
| Operating Profit | 1,020.10 | 955.70 | 1,005.20 | 815.50 | 769.60 |
| Interest | 31.20 | 29.50 | 45.20 | 24.10 | 27.70 |
| Gross Profit | 988.90 | 926.20 | 960.00 | 791.40 | 741.90 |
| Depreciation | 367.30 | 368.90 | 359.10 | 309.70 | 274.50 |
| Profit Before Tax | 621.60 | 557.30 | 600.90 | 481.70 | 467.40 |
| Current Tax | 159.90 | 104.40 | 115.60 | 87.60 | 46.80 |
| Fringe Benefit tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | -6.30 | -13.60 | 12.30 | 0.30 | 16.90 |
| Reported Net Profit | 468.00 | 466.50 | 473.00 | 393.80 | 403.70 |
| Extraordinary Items | 36.01 | -0.49 | 2.50 | -21.84 | 25.16 |
| Adjusted Net Profit | 431.99 | 466.99 | 470.50 | 415.64 | 378.54 |
| Adjustment below Net Profit | -0.10 | 3.80 | -70.20 | 0.00 | -0.10 |
| Profit/Loss Balance carried down | 3,396.10 | 2,976.10 | 2,573.30 | 2,179.50 | 1,775.90 |
| Statutory Appropriations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Appropriations | 50.30 | 50.30 | 0.00 | 0.00 | 0.00 |
| P & L Balance carried down | 3,813.70 | 3,396.10 | 2,976.10 | 2,573.30 | 2,179.50 |
| Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preference Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity Dividend (%) | 12.50 | 12.50 | 12.50 | 10.00 | 0.00 |
| Dividend Per Share(Rs) | 1.25 | 1.25 | 1.25 | 1.00 | 0.00 |
| Earnings Per Share-Unit Curr | 11.63 | 11.60 | 11.78 | 9.83 | 10.09 |
| Earnings Per Share(Adj)-Unit Curr | - | - | - | - | - |
| Book Value | 115.25 | 104.27 | 90.16 | 82.14 | 70.46 |
| Book Value(Adj)-Unit Curr | 115.25 | 104.27 | 90.16 | 82.14 | 70.46 |